Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 23 Mar 2026 – 20 Aug 2026, limited by Kotak Multi Factor Passive FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Multi Factor Passive FOF | Nifty 500 |
|---|---|---|
| 23 Mar 2026 | ₹100.00 | ₹100.00 |
| 05 Apr 2026 | ₹101.14 | ₹101.33 |
| 17 Apr 2026 | ₹110.09 | ₹110.67 |
| 30 Apr 2026 | ₹108.20 | ₹109.77 |
| 12 May 2026 | ₹107.44 | ₹107.92 |
| 25 May 2026 | ₹110.11 | ₹110.96 |
| 06 Jun 2026 | ₹107.42 | ₹108.72 |
| 19 Jun 2026 | ₹110.40 | ₹112.00 |
| 01 Jul 2026 | ₹109.90 | ₹111.84 |
| 14 Jul 2026 | ₹109.86 | ₹112.27 |
| 26 Jul 2026 | ₹109.64 | ₹110.88 |
| 08 Aug 2026 | ₹113.28 | ₹114.75 |
| 20 Aug 2026 | ₹111.59 | ₹113.79 |
| Metric | Kotak Mahindra · Regular NAV ₹11.13 Very High risk Unrated | Category median FoF Domestic · 148 funds |
|---|---|---|
| — | +7.03% | |
| — | +13.88% | |
| — | +11.19% | |
| — | +11.61% | |
| +11.59% | +10.54% | |
| +6.65% | — | |
| — | +12.35% | |
| — | +10.37% | |
| — | +8.94% | |
| Risk | ||
| 17.04% | 15.84% | |
| — | 0.70 | |
| — | 0.97 | |
| -4.96% | -19.67% | |
| Nifty 500 | — | |
| — | +1.35% | |
| — | 0.94 | |
| — | 97.2% | |
| — | 93.6% | |
| 0.46% | 0.58% | |
| ₹48.35Cr | ₹226.32Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 10% | |
| Abhishek Bisen | — | |
| 23 Mar 2026 | — | |
| — | — | |
| — | — | |
| 6.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.